
        <!DOCTYPE html>
        <html>
        <head>
            <title>Biohaven Pharmaceutical Holding Co Ltd. (BHVN) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Biohaven Pharmaceutical Holding Co Ltd. (BHVN)</h1>
                    <a href="index.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">12</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">4</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">3</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.03</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=74cd28e3cbeb2bfe1458e86b1f6c5b7ebb6b117ab74af7e6f14ca97ff4e3f210" target="_blank" rel="noopener noreferrer">Biohaven’s rare disease drug is ‘ready to ship on Day 1’ following FDA approval</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">CEO Vlad Coric said the company has a patient hub, payer managers and a small sales force set up to ensure a successful launch of Vyglxia, a brain medicine that could be approved this year....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4251da4aa79c0c6a518e6f6ecf35d8fff48bd00dc79697b879ff090e88fbe24e" target="_blank" rel="noopener noreferrer">Companies Like Biohaven (NYSE:BHVN) Could Be Quite Risky</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b5890c5cb111e573f19f659ea258a14c9f4cca72da1d0546b36e99f09d62ab3a" target="_blank" rel="noopener noreferrer">Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biohaven's troriluzole shows 50â70% SCA slowdown, with FDA review set for Q4 2025 and no advisory meeting required. Find out why BHVN stock is a strong buy....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ad7e790117f0730875bf08c1900f4caa6efbf81866fa6a8de218f6b34e030d66" target="_blank" rel="noopener noreferrer">Why Biohaven Stock Zoomed More Than 6% Higher Today</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.33
                                </span>
                            </div>
                            <div class="article-summary">It's always encouraging to get what appears to be good news from the FDA....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1bc761c33738cf7ac925ce50ddc42a208b42e00e3a504d471b5ea1e153bbe1be" target="_blank" rel="noopener noreferrer">FDA cancels adcomm on Biohaven drug; Catalent lays off staff</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.96
                                </span>
                            </div>
                            <div class="article-summary">Analysts found the agency's decision to cancel the meeting encouraging. Elsewhere, the Novo Holdings-owned CDMO cut about 350 staff in Maryland....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=28a7a3c0e4ed26d59620c79c32aa1ba9fae43105c0ed18080669c44fd1feffbe" target="_blank" rel="noopener noreferrer">Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.21
                                </span>
                            </div>
                            <div class="article-summary">Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for troriluzole for adult patients with Spinocerebellar Ataxia (SCA). In May 20...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=32314a0689955ef2c7647e87d6822b80eb963882fd9bc3d97725c8529cffd8c4" target="_blank" rel="noopener noreferrer">Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.47
                                </span>
                            </div>
                            <div class="article-summary">Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, troriluzole....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d18b6981fb89095ac541b6a26d0c0dad9ee01c402e91dd342a2aa989c8bebbc3" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Higher in Afternoon Trading</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks rose Friday afternoon, with the NYSE Health Care Index adding 1% and the Health C...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c218e73d8f27adacfefcfce8c07f9b0452f33385617cd9413dac81c59d59fe4a" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Advance Late Afternoon</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-22</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.82
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks rose late Friday afternoon, with the NYSE Health Care Index adding 1% and the Hea...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=133b017e0122042f7e50a2797586f584c98ce8115b12f1732d6924b816cef637" target="_blank" rel="noopener noreferrer">RBC says PTC Therapeutics CRL may signal difficulty for Biohaven</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-20</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.39
                                </span>
                            </div>
                            <div class="article-summary">RBC Capital analyst Leonid Timashev notes that PTC Therapeutics (PTCT) received a complete response letter for vatiquinone in Friedreich’s ataxia from the FDA, which the agency having noted that subst...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8d50332d629a741f27fa75560c7438e9db5370cb3c0562df3a2de6fc18d7053c" target="_blank" rel="noopener noreferrer">Leerink Lowers Biohaven (BHVN) PT to $50 Following Q2 Report, Acknowledging Positive Pipeline Progress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.15
                                </span>
                            </div>
                            <div class="article-summary">Biohaven Ltd. (NYSE:BHVN) is one of the best small cap stocks with biggest upside potential. On August 12, Leerink lowered the firm’s price target on Biohaven to $50 from $60, while keeping an Outperf...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=8aea7d9c110d168f5f3f9d4fbc4edd8c02e0ca02212bb2b776802c5de81eec12" target="_blank" rel="noopener noreferrer">Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat ...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        